Peer Review History

Original SubmissionDecember 20, 2021
Decision Letter - Joseph T. Wu, Editor, Tom Britton, Editor

Dear Mr Leng,

Thank you very much for submitting your manuscript "Assessing the impact of lateral flow testing on within-school SARS-CoV-2 transmission and absences: a modelling study" for consideration at PLOS Computational Biology. As with all papers reviewed by the journal, your manuscript was reviewed by members of the editorial board and by several independent reviewers. The reviewers appreciated the attention to an important topic. Based on the reviews, we are likely to accept this manuscript for publication, providing that you modify the manuscript according to the review recommendations.

Please prepare and submit your revised manuscript within 30 days. If you anticipate any delay, please let us know the expected resubmission date by replying to this email.

When you are ready to resubmit, please upload the following:

[1] A letter containing a detailed list of your responses to all review comments, and a description of the changes you have made in the manuscript. Please note while forming your response, if your article is accepted, you may have the opportunity to make the peer review history publicly available. The record will include editor decision letters (with reviews) and your responses to reviewer comments. If eligible, we will contact you to opt in or out

[2] Two versions of the revised manuscript: one with either highlights or tracked changes denoting where the text has been changed; the other a clean version (uploaded as the manuscript file).

Important additional instructions are given below your reviewer comments.

Thank you again for your submission to our journal. We hope that our editorial process has been constructive so far, and we welcome your feedback at any time. Please don't hesitate to contact us if you have any questions or comments.

Sincerely,

Joseph T. Wu

Associate Editor

PLOS Computational Biology

Tom Britton

Deputy Editor

PLOS Computational Biology

***********************

A link appears below if there are any accompanying review attachments. If you believe any reviews to be missing, please contact ploscompbiol@plos.org immediately:

[LINK]

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: This paper reports the results of a simulation study using an individual based model for the transmission of SARS-CoV2 within a school environment to compare and contrast the impact of alternative uses of rapid lateral flow tests in terms of the cumulative cases, absences and tests carried out.

The transmission model is necessarily largely assumptions based in the absence of useful empirical data at the school level to inform model development. Latent and infectious period distributions are based on the common set of empirical estimates from early in the pandemic used by most modelling studies.

The default configuration of the model assumes that transmission is well-mixed within year groups with limited exploration of alternative mixing patterns with assortative mixing between years and density versus frequency dependence (in supplementary information) and a range of different assumptions about prior immunity. Given the well mixed assumption the individual based structure is a convenience (compared to compartmental population models) rather than a necessity but will also likely have some computational performance advantages. Likewise, given this assumption the size of the school years (and school population) is the only specific parameter distinguishes the model from (smaller) primary schools.

The lack of an exploration of alternative transmission mechanisms is the largest limitation of the study. This is clearly described in the discussion, but I disagree with the justification (and necessity) for this assumption. We know from studies before the pandemic that social contact networks within schools are highly clustered - a network structure which is likely to limit and shape the rate of transmission within schools. The manuscript acknowledges this body of work but discounts the use of such data due to the likely changes in contact patterns due the pandemic. This is a valid point, however if anything social distancing measures might be expected to further fragment contacts and increase clustering. Network transmission scenarios (informed by empirical networks or simulated networks with similar patterns of clustering) would have provided a more robust evaluation of the sensitivity of results to model uncertainty and could very naturally be included within the chosen individual based modelling framework. Again, the time-critical nature of the policy relevance of such work makes such simplifying assumptions pragmatic (particularly given the lack of contemporary data) but it could be made clearer that such an exploration does not necessarily depend on carrying out time and resource consuming contact studies during a pandemic. The time-constraints under which work must be carried out to be relevant during a pandemic is a relevant and valid justification for the assumptions taken in itself and it would, in my view at least, be valuable to acknowledge it as such.

While parameter uncertainty is not, and cannot be, systematically explored given the type of data available, sensitivity of the results to parameter assumptions is addressed through a one at a time (OAT) analysis. This highlights the importance of the transmission parameters and test sensitivity which implies these parameters are likely to trade-off heavily against each other even if empirical data on transmission within schools was available.

The results are framed in terms of the trade-off between the number of infections averted, school absences and tests carried out. While the discussion acknowledges each of these have both a societal and economic costs the relative importance of each is not addressed which is vital for policy evaluation. Economic evaluations of public health control measures are routinely carried out using (albeit imperfect) measures such as DALYs. While I realise that there may not be reliable (or even any) quantitative estimates of these relative costs is this as they have not or cannot reasonably be evaluated. While the authors may well argue that this is a question of economics rather than biology, the policy implications of this work hinges on the answer whether this is a personal value judgement or something that can be more systematically quantified.

To sum up, this is a well written account of a careful assumptions based modelling exercise to explore the trade-offs between different testing strategies in schools to limit the impact of SARS-CoV and associated control measures. The methods are clearly documented both within the paper and with additional detail in supplementary information. Full source code to replicate the analysis is linked and a reasonable attempt at exploring parametric and model sensitivity of the results has been carried out. Necessarily carried out under time constraints and used as part of the package of advice given to the UK government this work has already demonstrated impact and it's publication is valuable in itself with respect to adding to the public record of the response to the ongoing pandemic.

Minor comments

Introduction: While it is clearly a NPI, practicing good hand hygiene is not, unlike the other listed NPIs, really a social restriction and not as far as I know enforced legally in the same way. In the context of the point being made it's inclusion at the start of the list distracts a little from the main point being made.

Reviewer #2: Thank you for this interesting simulation study on different variations of repetitive testing in schools.

The results would be more generalizable to other settings if a) it was not assumed that student participation was 100% in the main analysis (seems unlikely in most settings), and b) the error rates of the tests were adjusted to account for user error (both due to imperfect testing procedures, and possible changes due to changing variants).

In Figure 3, it would have been interested to see also the number of missed infections.

Thank you for pointing out in the limitations that these results are actually quite optimistic. It would seem that "user error" in the testing with LFT is probably somewhat high in this population. Were any simulations performed assuming higher error rates?

**********

Have the authors made all data and (if applicable) computational code underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data and code underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data and code should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data or code —e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: None

Reviewer #2: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: Yes: Sarah R Haile

Figure Files:

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Data Requirements:

Please note that, as a condition of publication, PLOS' data policy requires that you make available all data used to draw the conclusions outlined in your manuscript. Data must be deposited in an appropriate repository, included within the body of the manuscript, or uploaded as supporting information. This includes all numerical values that were used to generate graphs, histograms etc.. For an example in PLOS Biology see here: http://www.plosbiology.org/article/info%3Adoi%2F10.1371%2Fjournal.pbio.1001908#s5.

Reproducibility:

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

References:

Review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript.

If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

Revision 1

Attachments
Attachment
Submitted filename: Response to reviewers_ assessing.pdf
Decision Letter - Joseph T. Wu, Editor, Tom Britton, Editor

Dear Mr Leng,

We are pleased to inform you that your manuscript 'Assessing the impact of lateral flow testing strategies on within-school SARS-CoV-2 transmission and absences: a modelling study' has been provisionally accepted for publication in PLOS Computational Biology.

Before your manuscript can be formally accepted you will need to complete some formatting changes, which you will receive in a follow up email. A member of our team will be in touch with a set of requests.

Please note that your manuscript will not be scheduled for publication until you have made the required changes, so a swift response is appreciated.

IMPORTANT: The editorial review process is now complete. PLOS will only permit corrections to spelling, formatting or significant scientific errors from this point onwards. Requests for major changes, or any which affect the scientific understanding of your work, will cause delays to the publication date of your manuscript.

Should you, your institution's press office or the journal office choose to press release your paper, you will automatically be opted out of early publication. We ask that you notify us now if you or your institution is planning to press release the article. All press must be co-ordinated with PLOS.

Thank you again for supporting Open Access publishing; we are looking forward to publishing your work in PLOS Computational Biology. 

Best regards,

Joseph T. Wu

Associate Editor

PLOS Computational Biology

Tom Britton

Deputy Editor

PLOS Computational Biology

***********************************************************

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: Many thanks for comprehensively addressing my comments and suggestions.

Reviewer #2: No further comments.

**********

Have the authors made all data and (if applicable) computational code underlying the findings in their manuscript fully available?

The PLOS Data policy requires authors to make all data and code underlying the findings described in their manuscript fully available without restriction, with rare exception (please refer to the Data Availability Statement in the manuscript PDF file). The data and code should be provided as part of the manuscript or its supporting information, or deposited to a public repository. For example, in addition to summary statistics, the data points behind means, medians and variance measures should be available. If there are restrictions on publicly sharing data or code —e.g. participant privacy or use of data from a third party—those must be specified.

Reviewer #1: Yes

Reviewer #2: Yes

**********

PLOS authors have the option to publish the peer review history of their article (what does this mean?). If published, this will include your full peer review and any attached files.

If you choose “no”, your identity will remain anonymous but your review may still be made public.

Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy.

Reviewer #1: No

Reviewer #2: No

Formally Accepted
Acceptance Letter - Joseph T. Wu, Editor, Tom Britton, Editor

PCOMPBIOL-D-21-02289R1

Assessing the impact of lateral flow testing strategies on within-school SARS-CoV-2 transmission and absences: a modelling study

Dear Dr Leng,

I am pleased to inform you that your manuscript has been formally accepted for publication in PLOS Computational Biology. Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting PLOS Computational Biology and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Anita Estes

PLOS Computational Biology | Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom ploscompbiol@plos.org | Phone +44 (0) 1223-442824 | ploscompbiol.org | @PLOSCompBiol

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .